Texas Investigates UnitedHealth Over Alleged Delays in Patient Care
On October 5, 2026, Texas Attorney General Ken Paxton launched an investigation into UnitedHealth Group Inc (NYSE: UNH) over allegations of misleading and illegal practices that may have hindered Texans from accessing necessary medical care. The probe focuses on claims that UnitedHealth incentivized nursing facilities to delay hospital admissions, potentially compromising patient treatment. The investigation follows a case where a Texas resident faced unexpected out-of-pocket expenses after an initially approved medical procedure was rescinded.
UnitedHealth, a major player in the healthcare industry, operates through its UnitedHealthcare and Optum segments, offering health benefits and value-based care services. The company boasts a strong GF Score™ of 81/100, reflecting solid financial health and operational performance. Despite this, the investigation introduces regulatory uncertainty for the insurer.
From a financial perspective, UnitedHealth offers a dividend yield of 2.48% with a payout ratio of 58%, supported by a 3-year dividend growth rate of 10.9%. The stock is currently 37.3% undervalued relative to its GF Value™ of $591.67. Institutional ownership remains high at 88.23%, though insider activity shows no purchases and modest sales totaling $0.9 million over the past year.
The GF Score™ highlights UnitedHealth’s strengths in profitability and momentum, with moderate ratings for financial strength and growth. The valuation metric ranks lower at 4/10, aligning with the stock’s current undervaluation. Investors are advised to monitor the ongoing investigation but may find UNH’s dividend reliability and intrinsic value appealing.